Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Edward Ross Ashwood

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-Pathology
Phone720/848-7064

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Palomaki GE, Wyatt P, Best RG, Lepage N, Ashwood ER, Souers RJ, Thorson JA. Assessment of laboratories offering cell-free (cf) DNA screening for Down syndrome: results of the 2018 College of American Pathology External Educational Exercises. Genet Med. 2020 04; 22(4):777-784. PMID: 31929509.
      View in: PubMed
    2. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 34279151.
      View in: PubMed
    3. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 22536271.
      View in: PubMed
    4. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 26133556.
      View in: PubMed
    5. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 25557844.
      View in: PubMed
    6. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 8149604.
      View in: PubMed
    7. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 17621360.
      View in: PubMed
    8. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 24027169.
      View in: PubMed
    9. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 11165600.
      View in: PubMed
    10. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 19896791.
      View in: PubMed
    11. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18466033.
      View in: PubMed
    12. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 18476029.
      View in: PubMed
    13. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 2245210.
      View in: PubMed
    14. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 2403778.
      View in: PubMed
    15. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 2225081.
      View in: PubMed
    16. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1988877.
      View in: PubMed
    17. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 3753665.
      View in: PubMed
    18. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 3943183.
      View in: PubMed
    19. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15043467.
      View in: PubMed
    20. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 2228651.
      View in: PubMed
    21. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 21213585.
      View in: PubMed
    22. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15872232.
      View in: PubMed
    23. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 9142369.
      View in: PubMed
    24. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 15737021.
      View in: PubMed
    25. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 26276766.
      View in: PubMed
    26. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 10783496.
      View in: PubMed
    27. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 8445605.
      View in: PubMed
    28. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 9210969.
      View in: PubMed
    29. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 1424111.
      View in: PubMed
    30. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 10116936.
      View in: PubMed
    31. Rulifson G, Bielefeldt AR. Evolution of Students' Varied Conceptualizations About Socially Responsible Engineering: A Four Year Longitudinal Study. Sci Eng Ethics. 2019 06; 25(3):939-974. PMID: 10148933.
      View in: PubMed
    32. Kaul KL, Sabatini LM, Tsongalis GJ, Caliendo AM, Olsen RJ, Ashwood ER, Bale S, Benirschke R, Carlow D, Funke BH, Grody WW, Hayden RT, Hegde M, Lyon E, Murata K, Pessin M, Press RD, Thomson RB. The Case for Laboratory Developed Procedures: Quality and Positive Impact on Patient Care. Acad Pathol. 2017 Jan-Dec; 4:2374289517708309. PMID: 28815200.
      View in: PubMed
    33. Weinert K, Gyorda P, Rifai N, Evans S, Kaufman HW, Eby CS, Ashwood ER, Moore N. Triangulating Dynamic of Clinical Laboratory Testing. Clin Chem. 2015 Nov; 61(11):1320-7. PMID: 26378064.
      View in: PubMed
    34. Walker BS, Jackson BR, LaGrave D, Ashwood ER, Schmidt RL. A cost-effectiveness analysis of cell free DNA as a replacement for serum screening for Down syndrome. Prenat Diagn. 2015 May; 35(5):440-6. PMID: 25273838.
      View in: PubMed
    35. Palomaki GE, Ashwood ER, Best RG, Lambert-Messerlian G, Knight GJ. Is maternal plasma DNA testing impacting serum-based screening for aneuploidy in the United States? Genet Med. 2015 Nov; 17(11):897-900. PMID: 25834952.
      View in: PubMed
    36. Schmidt RL, Garcia CA, Panlener J, Ashwood ER, Jackson BR, Hussong JW. An analysis of clinical consultation activities in clinical chemistry: implications for transformation and resident training in chemical pathology. Arch Pathol Lab Med. 2014 May; 138(5):671-7. PMID: 24786125.
      View in: PubMed
    37. Ashwood ER, Palomaki GE. A new era in noninvasive prenatal testing. N Engl J Med. 2013 11 28; 369(22):2164. PMID: 24283243.
      View in: PubMed
    38. Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. Response. Chest. 2013 Nov; 144(5):1733-1734. PMID: 24189873.
      View in: PubMed
    39. Palomaki GE, Knight GJ, Ashwood ER, Best RG, Haddow JE. Screening for down syndrome in the United States: results of surveys in 2011 and 2012. Arch Pathol Lab Med. 2013 Jul; 137(7):921-6. PMID: 23808464.
      View in: PubMed
    40. Killeen AA, Ashwood ER, Ventura CB, Styer P. Recent trends in performance and current state of creatinine assays. Arch Pathol Lab Med. 2013 Apr; 137(4):496-502. PMID: 23544939.
      View in: PubMed
    41. Bornhorst JA, Greene DN, Ashwood ER, Grenache DG. a1-Antitrypsin phenotypes and associated serum protein concentrations in a large clinical population. Chest. 2013 Apr; 143(4):1000-1008. PMID: 23632999.
      View in: PubMed
    42. Scott MG, Ashwood ER, Annesley TM, Leonard DG, Burgess MC. FDA oversight of laboratory-developed tests: is it necessary, and how would it impact clinical laboratories? Clin Chem. 2013 Jul; 59(7):1017-22. PMID: 23536512.
      View in: PubMed
    43. Kushnir MM, Crockett DK, Cloud JL, Ashwood ER, Rockwood AL. Exploratory study of proteins in urine of patients with histoplasma antigenuria. J Chromatogr B Analyt Technol Biomed Life Sci. 2012 Feb 01; 883-884:147-54. PMID: 21963477.
      View in: PubMed
    44. Marques MB, Anastasi J, Ashwood E, Baron B, Fitzgerald R, Fung M, Krasowski M, Laposata M, Nester T, Rinder HM. The clinical pathologist as consultant. Am J Clin Pathol. 2011 Jan; 135(1):11-2. PMID: 21173119.
      View in: PubMed
    45. Erickson JA, Lu J, Smith JJ, Bornhorst JA, Grenache DG, Ashwood ER. Immunoassay for quantifying squamous cell carcinoma antigen in serum. Clin Chem. 2010 Sep; 56(9):1496-9. PMID: 20601447.
      View in: PubMed
    46. Talbert ML, Ashwood ER, Brownlee NA, Clark JR, Horowitz RE, Lepoff RB, Neumann A, Otis CN, Powell SZ, Sodeman TM. Resident preparation for practice: a white paper from the College of American Pathologists and Association of Pathology Chairs. Arch Pathol Lab Med. 2009 Jul; 133(7):1139-47. PMID: 19642741.
      View in: PubMed
    47. Slev PR, Williams BG, Harville TO, Ashwood ER, Bornhorst JA. Efficacy of the detection of the alpha1-antitrypsin "Z" deficiency variant by routine serum protein electrophoresis. Am J Clin Pathol. 2008 Oct; 130(4):568-72. PMID: 18794049.
      View in: PubMed
    48. Erickson JA, Aldeen WE, Grenache DG, Ashwood ER. Evaluation of a fecal pancreatic elastase-1 enzyme-linked immunosorbent assay: Assessment versus an established assay and implication in classifying pancreatic function. Clin Chim Acta. 2008 Nov; 397(1-2):87-91. PMID: 18706899.
      View in: PubMed
    49. Bornhorst JA, Calderon FR, Procter M, Tang W, Ashwood ER, Mao R. Genotypes and serum concentrations of human alpha-1-antitrypsin "P" protein variants in a clinical population. J Clin Pathol. 2007 Oct; 60(10):1124-8. PMID: 17906067.
      View in: PubMed
    50. Cloud JL, Bauman SK, Pelfrey JM, Ashwood ER. Biased report on the IMMY ALPHA Histoplasma antigen enzyme immunoassay for diagnosis of histoplasmosis. Clin Vaccine Immunol. 2007 Oct; 14(10):1389-90; author reply 1390-1. PMID: 17923498.
      View in: PubMed
    51. Bornhorst JA, Procter M, Meadows C, Ashwood ER, Mao R. Evaluation of an integrative diagnostic algorithm for the identification of people at risk for alpha1-antitrypsin deficiency. Am J Clin Pathol. 2007 Sep; 128(3):482-90. PMID: 17709323.
      View in: PubMed
    52. Cloud JL, Bauman SK, Neary BP, Ludwig KG, Ashwood ER. Performance characteristics of a polyclonal enzyme immunoassay for the quantitation of Histoplasma antigen in human urine samples. Am J Clin Pathol. 2007 Jul; 128(1):18-22. PMID: 17580268.
      View in: PubMed
    53. Bornhorst JA, Cousin R, Pili AT, Erickson JA, Ashwood ER. Evaluation of the efficacy of chloroform extraction of amniotic fluid bilirubin. Clin Chem. 2006 Nov; 52(11):2120-1. PMID: 17068177.
      View in: PubMed
    54. Pysher TJ, Bach PR, Geaghan SM, Hamilton MS, Laposata M, Lockitch G, Brugnara C, Coffin CM, Pasquali M, Rinaldo P, Roberts WL, Rutledge JC, Ashwood ER, Blaylock RC, Campos JM, Goldsmith B, Jones PM, Lim M, Meikle AW, Perkins SL, Perry DA, Petti CA, Rogers BB, Steele PE, Weiss RL, Woods G. Teaching pediatric laboratory medicine to pathology residents. Arch Pathol Lab Med. 2006 Jul; 130(7):1031-8. PMID: 16831030.
      View in: PubMed
    55. Konnick EQ, Erali M, Ashwood ER, Hillyard DR. Evaluation of the COBAS amplicor HBV monitor assay and comparison with the ultrasensitive HBV hybrid capture 2 assay for quantification of hepatitis B virus DNA. J Clin Microbiol. 2005 Feb; 43(2):596-603. PMID: 15695651.
      View in: PubMed
    56. Lo SF, Doumas BT, Ashwood ER. Bilirubin proficiency testing using specimens containing unconjugated bilirubin and human serum: results of a College of American Pathologists study. Arch Pathol Lab Med. 2004 Nov; 128(11):1219-23. PMID: 15504055.
      View in: PubMed
    57. Chapman JF, Ashwood ER, Feld R, Wu AH. Evaluation of two-dimensional cytometric lamellar body counts on the ADVIA 120 hematology system for estimation of fetal lung maturation. Clin Chim Acta. 2004 Feb; 340(1-2):85-92. PMID: 14734199.
      View in: PubMed
    58. Lo SF, Doumas BT, Ashwood ER. Performance of bilirubin determinations in US laboratories--revisited. Clin Chem. 2004 Jan; 50(1):190-4. PMID: 14633931.
      View in: PubMed
    59. Erickson JA, Cousin R, Wu JT, Ashwood ER. Quantitative spectrophotometric microplate assay for angiotensin-converting enzyme in cerebrospinal fluid. Clin Chem. 2003 Jun; 49(6 Pt 1):970-2. PMID: 12766000.
      View in: PubMed
    60. Hawker CD, Garr SB, Hamilton LT, Penrose JR, Ashwood ER, Weiss RL. Automated transport and sorting system in a large reference laboratory: part 1. Evaluation of needs and alternatives and development of a plan. Clin Chem. 2002 Oct; 48(10):1751-60. PMID: 12324492.
      View in: PubMed
    61. Hawker CD, Roberts WL, Garr SB, Hamilton LT, Penrose JR, Ashwood ER, Weiss RL. Automated transport and sorting system in a large reference laboratory: part 2. Implementation of the system and performance measures over three years. Clin Chem. 2002 Oct; 48(10):1761-7. PMID: 12324493.
      View in: PubMed
    62. Coffin CM, Hamilton MS, Pysher TJ, Bach P, Ashwood E, Schweiger J, Monahan D, Perry D, Rogers BB, Brugnara C, Rutledge J, Weiss R, Ash O, Hill H, Meikle W, Roberts W, Geaghan S. Pediatric laboratory medicine: current challenges and future opportunities. Am J Clin Pathol. 2002 May; 117(5):683-90. PMID: 12090415.
      View in: PubMed
    63. Konnick EQ, Erali M, Ashwood ER, Hillyard DR. Performance characteristics of the COBAS Amplicor Hepatitis C Virus (HCV) Monitor, Version 2.0, International Unit assay and the National Genetics Institute HCV Superquant assay. J Clin Microbiol. 2002 Mar; 40(3):768-73. PMID: 11880391.
      View in: PubMed
    64. Willman JH, Hill HR, Martins TB, Jaskowski TD, Ashwood ER, Litwin CM. Multiplex analysis of heterophil antibodies in patients with indeterminate HIV immunoassay results. Am J Clin Pathol. 2001 May; 115(5):764-9. PMID: 11345842.
      View in: PubMed
    65. Neerhof MG, Dohnal JC, Ashwood ER, Lee IS, Anceschi MM. Lamellar body counts: a consensus on protocol. Obstet Gynecol. 2001 Feb; 97(2):318-20. PMID: 11165603.
      View in: PubMed
    66. Dufour DR, Ashwood ER, Nolte FS, Seeff LB. More on viral hepatitis. Am J Clin Pathol. 2000 Oct; 114(4):660-4. PMID: 11026110.
      View in: PubMed
    67. Erali M, Ashwood ER, Hillyard DR. Performance characteristics of the COBAS AMPLICOR hepatitis C virus MONITOR Test, version 2.0. Am J Clin Pathol. 2000 Aug; 114(2):180-7. PMID: 10941332.
      View in: PubMed
    68. Ashwood ER. Acute coronary syndromes: from bench to bedside--the Twenty-first annual Arnold O. Beckman Conference in Clinical Chemistry. Clin Chem. 1998 Aug; 44(8 Pt 2):1795-7. PMID: 9702988.
      View in: PubMed
    69. Ashwood ER. Standards of laboratory practice: evaluation of fetal lung maturity. National Academy of Clinical Biochemistry. Clin Chem. 1997 Jan; 43(1):211-4. PMID: 8990255.
      View in: PubMed
    70. Nuttall KL, Pingree SS, Ashwood ER. Reference intervals for 24-hour and random urine porphyrins. Ann Clin Lab Sci. 1996 Jul-Aug; 26(4):313-22. PMID: 8800431.
      View in: PubMed
    71. Balis UJ, Aller RD, Ashwood ER. Informatics training in U.S. pathology residency programs. Results of a survey. Am J Clin Pathol. 1993 Oct; 100(4 Suppl 1):S44-7. PMID: 8311028.
      View in: PubMed
    72. Barman BN, Ashwood ER, Giddings JC. Separation and size distribution of red blood cells of diverse size, shape, and origin by flow/hyperlayer field-flow fractionation. Anal Biochem. 1993 Jul; 212(1):35-42. PMID: 8368513.
      View in: PubMed
    73. Ashwood ER, Palmer SE, Taylor JS, Pingree SS. Lamellar body counts for rapid fetal lung maturity testing. Obstet Gynecol. 1993 Apr; 81(4):619-24. PMID: 8459979.
      View in: PubMed
    74. Petersen RS, Bailey PL, Kalameghan R, Ashwood ER. Prolonged neuromuscular block after mivacurium. Anesth Analg. 1993 Jan; 76(1):194-6. PMID: 8418724.
      View in: PubMed
    75. Ashwood ER, Palmer SE, Lenke RR. Rapid fetal lung maturity testing: commercial versus NBD-phosphatidylcholine assay. Obstet Gynecol. 1992 Dec; 80(6):1048-53. PMID: 1448250.
      View in: PubMed
    76. Ashwood ER. Evaluating health and maturation of the unborn: the role of the clinical laboratory. Clin Chem. 1992 Aug; 38(8B Pt 2):1523-9. PMID: 1386562.
      View in: PubMed
    77. Weilert M, Ashwood ER, Skinner M. The ins and outs of laboratory information systems. Combining the hospital and reference laboratory. Clin Lab Med. 1991 Mar; 11(1):153-69. PMID: 2040139.
      View in: PubMed
    78. Salyer JL, Bohnsack JF, Knape WA, Shigeoka AO, Ashwood ER, Hill HR. Mechanisms of tumor necrosis factor-alpha alteration of PMN adhesion and migration. Am J Pathol. 1990 Apr; 136(4):831-41. PMID: 2183625.
      View in: PubMed
    79. Ashwood ER, Oldroyd RG, Palmer SE. Measuring the number of lamellar body particles in amniotic fluid. Obstet Gynecol. 1990 Feb; 75(2):289-92. PMID: 2300359.
      View in: PubMed
    80. Ulirsch RC, Ashwood ER, Noce P. Security in the clinical laboratory. Guidelines for managing the information resource. Arch Pathol Lab Med. 1990 Jan; 114(1):89-93. PMID: 2294872.
      View in: PubMed
    81. Newton JA, Ashwood ER, Yang KD, Augustine NH, Hill HR. Effect of pentoxifylline on developmental changes in neutrophil cell surface mobility and membrane fluidity. J Cell Physiol. 1989 Sep; 140(3):427-31. PMID: 2550471.
      View in: PubMed
    82. Lenke RR, Guerrieri J, Nemes JM, Kurczynski TW, French B, Gray M, Schut H, Ashwood ER. Elevated maternal serum alpha-fetoprotein values. How low is high? J Reprod Med. 1989 Aug; 34(8):511-6. PMID: 2478705.
      View in: PubMed
    83. Terreros DA, Knight JA, Ashwood ER. Nickel inhibition of the osmotic-sensitive ionic cellular channels. Ann Clin Lab Sci. 1988 Nov-Dec; 18(6):444-50. PMID: 2467601.
      View in: PubMed
    84. Ashwood ER, Chamberlain BV. Binding of fluorescent phosphatidylcholine in amniotic fluid. Obstet Gynecol. 1988 Mar; 71(3 Pt 1):370-4. PMID: 3347421.
      View in: PubMed
    85. Talt JF, Foerder CA, Ashwood ER, Benedetti TJ. Prospective clinical evaluation of an improved fluorescence polarization assay for predicting fetal lung maturity. Clin Chem. 1987 Apr; 33(4):554-8. PMID: 3829389.
      View in: PubMed
    86. Ashwood ER, Cheng E, Luthy DA. Maternal serum alpha-fetoprotein and fetal trisomy-21 in women 35 years and older: implications for alpha-fetoprotein screening programs. Am J Med Genet. 1987 Mar; 26(3):531-9. PMID: 2436476.
      View in: PubMed
    87. Foerder CA, Tait JF, Franklin RW, Ashwood ER. Improved fluorescence polarization assay for use in evaluating fetal lung maturity. II. Analytical evaluation and comparison with the lecithin/sphingomyelin ratio. Clin Chem. 1986 Feb; 32(2):255-9. PMID: 3753666.
      View in: PubMed
    88. Lenke RR, Ashwood ER, Cyr DR, Gravett M, Smith JR, Stenchever MA. Genetic amniocentesis: significance of intraamniotic bleeding and placental location. Obstet Gynecol. 1985 Jun; 65(6):798-801. PMID: 2582322.
      View in: PubMed
    89. Ashwood ER, Kost G, Kenny M. Temperature correction of blood-gas and pH measurements. Clin Chem. 1983 Nov; 29(11):1877-85. PMID: 6354511.
      View in: PubMed
    Ashwood's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description

    Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)